loadpatents
name:-0.00876784324646
name:-0.0086669921875
name:-0.003242015838623
Gilbert; Kevin F. Patent Filings

Gilbert; Kevin F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gilbert; Kevin F..The latest application filed is for "hcv ns3 protease inhibitors".

Company Profile
0.10.9
  • Gilbert; Kevin F. - Barto PA
  • Gilbert; Kevin F. - Bechtelsville PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
Grant 9,624,208 - Pero , et al. April 18, 2
2017-04-18
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
Grant 9,273,040 - Layton , et al. March 1, 2
2016-03-01
HCV NS3 Protease Inhibitors
App 20150266897 - Liverton; Nigel J. ;   et al.
2015-09-24
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20150252034 - Pero; Joseph E. ;   et al.
2015-09-10
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels
App 20140303143 - Layton; Mark E. ;   et al.
2014-10-09
Tetrahydroquinoline amide M1 receptor positive allosteric modulators
Grant 8,815,902 - Gilbert , et al. August 26, 2
2014-08-26
Hcv Ns3 Protease Inhibitors
App 20130178413 - McCauley; John A. ;   et al.
2013-07-11
HCV NS3 protease inhibitors
Grant 8,461,107 - Liverton , et al. June 11, 2
2013-06-11
Tetrahydroquinoline Amide M1 Receptor Positive Allosteric Modulators
App 20130090352 - Gilbert; Kevin F. ;   et al.
2013-04-11
Hcv Ns3 Protease Inhibitors
App 20110046161 - Liverton; Nigel J. ;   et al.
2011-02-24
HCV NS3 Protease Inhibitors
App 20100099695 - Liverton; Nigel J. ;   et al.
2010-04-22
Spirotricyclic substituted azacycloalkane derivatives and uses thereof
Grant 6,387,893 - Evans , et al. May 14, 2
2002-05-14
Tocolytic oxytocin receptor antagonists
Grant 5,756,504 - Bock , et al. May 26, 1
1998-05-26
Tocolytic oxytocin receptor antagonists
Grant 5,464,788 - Bock , et al. November 7, 1
1995-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed